GETINGE PE Ratio 2016-2024 | GNGBY
Current and historical p/e ratio for GETINGE (GNGBY) from 2016 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. GETINGE PE ratio as of February 04, 2025 is 17.94.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| GETINGE PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.288B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $160.880B | 29.74 |
| Elevance Health (ELV) | United States | $91.772B | 12.00 |
| Cencora (COR) | United States | $49.134B | 18.48 |
| Natera (NTRA) | United States | $23.357B | 0.00 |
| DiDi Global (DIDIY) | China | $22.601B | 0.00 |
| ICON (ICLR) | Ireland | $16.423B | 14.63 |
| Revvity (RVTY) | United States | $15.350B | 25.74 |
| Avantor (AVTR) | United States | $15.164B | 22.74 |
| BioMerieux (BMXMF) | France | $14.363B | 0.00 |
| Viatris (VTRS) | United States | $13.464B | 4.15 |
| CochLear (CHEOY) | Australia | $13.043B | 0.00 |
| Solventum (SOLV) | United States | $12.794B | 0.00 |
| Doximity (DOCS) | United States | $11.033B | 64.94 |
| Medpace Holdings (MEDP) | United States | $10.852B | 30.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.405B | 0.00 |
| HealthEquity (HQY) | United States | $9.569B | 48.01 |
| Charles River Laboratories (CRL) | United States | $8.425B | 16.28 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 28.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 87.41 |
| Organon (OGN) | United States | $4.007B | 4.04 |
| Sotera Health (SHC) | United States | $3.883B | 20.77 |
| Surgery Partners (SGRY) | United States | $3.240B | 36.94 |
| Concentras Parent (CON) | United States | $2.968B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
| PACS (PACS) | United States | $2.214B | 0.00 |
| Premier (PINC) | United States | $2.178B | 11.33 |
| Ardent Health Partners (ARDT) | United States | $2.141B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.056B | 0.00 |
| Progyny (PGNY) | United States | $1.973B | 39.95 |
| GoodRx Holdings (GDRX) | United States | $1.818B | 47.70 |
| Teladoc Health (TDOC) | United States | $1.749B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.376B | 0.00 |
| CareDx (CDNA) | United States | $1.250B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.201B | 11.75 |
| AMN Healthcare Services Inc (AMN) | United States | $1.048B | 7.09 |
| Embecta (EMBC) | United States | $1.042B | 7.29 |
| Establishment Labs Holdings (ESTA) | $0.897B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.515B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.499B | 18.81 |
| Sonida Senior Living (SNDA) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| QDM (QDMI) | Hong Kong, SAR China | $0.412B | 0.00 |
| MultiPlan (MPLN) | United States | $0.295B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.295B | 0.00 |
| Nutex Health (NUTX) | United States | $0.259B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.108B | 18.32 |
| Oncology Institute (TOI) | United States | $0.076B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| ModivCare (MODV) | United States | $0.057B | 3.10 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |